May 09, 2012
Dell to host NMTRC Symposium 2012, annual meeting of biomedical researchers, pediatric oncologists, parents and advocates
May 8 — The team of parents, genetic and translational medicine scientists and pediatric oncologists trailblazing personalized medicine in the treatment of deadly pediatric cancers is convening in Austin to discuss the status of the world's first personalized medicine clinical trial for pediatric cancer and plan next steps at the NMTRC Symposium 2012. Neuroblastoma affects 1 in 100,000 children and is responsible for 1 in 7 pediatric cancer deaths.
Parents, advocates, oncologists from the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) and biomedical researchers from the Translational Genomics Research Institute (TGen), who are using high performance computing and cloud technology from Dell to identify targeted treatments based on the specific genetic vulnerabilities of each child's tumor – an approach that could be used to treat all pediatric and adult cancers in the future.
Personalized medicine – treatment based on the specific vulnerabilities of each tumor – is overcoming longstanding barriers to treatment of pediatric cancer. There has been only one new treatment for pediatric cancer approved by the FDA since the 1980s, compared to 50 treatments approved for adult cancer in this same timeframe. As a result, pediatric oncologists use treatments designed for adults to treat children, with toxic side effects that are frequently as physically detrimental to the child as the cancer itself.
The following events will be available via live-stream:
1-2 pm CT: Keynote: “Molecular-Profiling for Optimized Precision Therapy,” Dr. Timothy Triche, University of Southern California/ Children’s Hospital Los Angeles
2-4 pm CT: Panel Discussion: “Kids Cloud: Access to Data Boundaries”
Dr. Melinda Merchant - National Cancer Institute
Dr. Gary Marchant - Arizona State University
Nancy Goodman - Kids V. Cancer Foundation
Patrick Lacey - Friends of Will Foundation
Andy Mikulak - Max’s Ring of Fire Foundation
Dr. Giselle Sholler - Van Andel Institute
Dr. Spyro Mousses - Translational Genomics Research Institute
Dr. James Coffin - Dell
Source: Dell Inc.
10/30/2013 | Cray, DDN, Mellanox, NetApp, ScaleMP, Supermicro, Xyratex | Creating data is easy… the challenge is getting it to the right place to make use of it. This paper discusses fresh solutions that can directly increase I/O efficiency, and the applications of these solutions to current, and new technology infrastructures.
10/01/2013 | IBM | A new trend is developing in the HPC space that is also affecting enterprise computing productivity with the arrival of “ultra-dense” hyper-scale servers.
Ken Claffey, SVP and General Manager at Xyratex, presents ClusterStor at the Vendor Showdown at ISC13 in Leipzig, Germany.
Join HPCwire Editor Nicole Hemsoth and Dr. David Bader from Georgia Tech as they take center stage on opening night at Atlanta's first Big Data Kick Off Week, filmed in front of a live audience. Nicole and David look at the evolution of HPC, today's big data challenges, discuss real world solutions, and reveal their predictions. Exactly what does the future holds for HPC?